ArticleJournal of clinical pharmacology2026

Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.

Rosie Z Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.